Home » Asia to Dominate Growth in Pharma Contract Manufacturing
Asia to Dominate Growth in Pharma Contract Manufacturing
PharmaManufacturing.com
07/21/2010
PRLog (Press Release) – Jul 21, 2010 – The global pharmaceutical industry has experienced numerous changes in terms of market trends over the recent few years. With the mounting cost pressure on the pharmaceutical companies due to the healthcare cost cutting measures in various countries, the trend of drugs contract manufacturing at low cost has become very important. As per a new research report, “Global Contract Manufacturing Market Analysis”, the global contract manufacturing market is expected to grow at a CAGR of around 12% during 2010-2012.
Research by RNCOS has found that currently North America is dominating the overall contract manufacturing market. However, the Asian countries have made most of the progress in terms of production capacity and facilities up gradation in recent years. The low cost manufacturing services are the major advantage that these CMOs in Asia have gained over other regions. In this regard, the report provides complete information and analysis of various pharmaceutical contract manufacturing destinations in Asia such as India, China, Vietnam, Bangladesh and South Korea.
RNCOS has studied various country level contract manufacturing markets based on their export volume of drugs and pharmaceuticals and production capacities. Besides, the report includes key contract manufacturers in these countries along with their business details. This will help the client in getting a clear overview of the overall market. Moreover, some other emerging market trends like Biomanufacturing and GMP regulation issues have also been studied in the report.
“Global Contract Manufacturing Market Analysis” is an outcome of extensive research and thorough analysis of the fast-growing pharmaceutical contract manufacturing industry worldwide. The report discusses market structure, current and past market performance and factors critical to the success of the industry. Moreover, the report gives industry forecast based on correlation of past drivers, challenges and opportunities for expansion. We have also identified all the key players in the Competitor Analysis section of the report. The section talks about the business profile and strategic moves of leading players operating in the sector. This report will help those clients planning to invest in the contract manufacturing industry or looking to outsource manufacturing of their products.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM265.htm
More News:
-
02/09/2012
Watchdog Fines Ernst & Young $2 million Over Medicis Pharma Corp. AuditsFrom Reuters.com
The watchdog board for corporate auditors on Wednesday said it has imposed a $2 million penalty, its largest fine ever, on accounting and consulting firm Ernst & Young LLP in a settlement involving past audits of Medicis Pharmaceutical Corp.
-
02/09/2012
FDA Issues Draft Guidance on Biosimilar Product Development
The U.S. Food and Drug Administration today issued three draft guidance documents on biosimilar product development to assist industry in developing such products in the United States.
-
02/08/2012
Biomedical Industry Loses Momentum in California, According to 2012 Report
Innovation slows as productivity in the Biomedical industry declines
-
02/02/2012
Pfizer Baby Boom? Pfizer's Official StatementFrom Pharmalot.com
About nine months from now, a new phenomenon may appear at a hospital near you: the Pfizer baby. Why? The drugmaker has taken the embarrassing step of recalling 1 million packets of birth control pills due to a packaging error. Hear EVP and CMO, Freda Lewis-Hall's read Pfizer's official statement.
-
02/02/2012
News: AstraZeneca To Cut 7,300 JobsFrom MarketWatch.com
Drug firm AstraZeneca on Thursday said it would cut approximately 7,300 jobs as part of an ongoing initiative to reduce costs and drive innovation.
-
02/01/2012
Pfizer Recalls 1 Million Birth Control Packs for Error That Could Cause Unintended PregnancyFrom WashingtonPost.com
Pfizer Inc. is recalling 1 million packets of birth control pills due to a packaging error that could raise the risk of an accidental pregnancy by leaving women with an inadequate dose. The problem affects 14 lots of Lo/Ovral-28 tablets and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets. Both products are manufactured by Pfizer and marketed in the U.S. by Akrimax Rx Products under the Akrimax Pharmaceuticals brand.
-
01/26/2012
News: Abbott Labs Cuts 700 Manufacturing JobsFrom WashingtonPost.com
Medical device and drugmaker Abbott Laboratories said Wednesday it will lay off 700 employees as part of ongoing restructuring efforts. A company spokeswoman said most of the layoffs will affect employees who manufacture the company’s heart stents and diagnostic tests.
- 01/24/2012 ISPE Announces 2012 FOYA Winners
- 01/24/2012 Genzyme Gains Approval for Framingham Site, a Boost to Fabrazyme Production
-
01/19/2012
Big Pharma Execs May Wish They'd Never Heard Of Paula DeenFrom Forbes.com
Novo Nordisk has nabbed Paula Deen as a new spokeswoman to help raise awareness about type 2 diabetes. Many in the drug industry wish it weren’t so, but without major legal and regulatory changes, such matches between celebs and drug firms are as certain as the sun rising in the east.
- All news »
Get Connected Now!
- Featured White Papers

Print page